|
1
|
Park JY, Zhang F and Andreassen PR: PALB2:
The hub of a network of tumor suppressors involved in DNA damage
responses. Biochim Biophys Acta. 1846:263–275. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Simhadri S, Vincelli G, Huo Y, Misenko S,
Foo TK, Ahlskog J, Sørensen CS, Oakley GG, Ganesan S, Bunting SF
and Xia B: PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint
response. Oncogene. 38:1585–1596. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hanenberg H and Andreassen PR: PALB2
(partner and localizer of BRCA2). Atlas Genet Cytogenet Oncol
Haematol. 22:484–290. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hamdan O and Nowak KM: Gene of the month:
PALB2. J Clin Pathol. 76:73–75. 2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
AlHarbi M, Mobark NA, AlJabarat WAR,
ElBardis H, AlSolme E, Hamdan AB, AlFakeeh AH, AlMushawah F,
AlHarthi F, AlSharm AA, et al: Investigating the prevalence of
pathogenic variants in Saudi Arabian patients with familial cancer
using a multigene next generation sequencing panel. Oncotarget.
14:580–594. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yang X, Leslie G, Doroszuk A, Schneider S,
Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I,
et al: Cancer risks associated with germline PALB2 pathogenic
variants: An international study of 524 families. J Clin Oncol.
38:674–685. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Taylor A, Brady AF, Frayling IM, Hanson H,
Tischkowitz M, Turnbull C and Side L: UK Cancer Genetics Group
(UK-CGG). Consensus for genes to be included on cancer panel tests
offered by UK genetics services: Guidelines of the UK cancer
genetics group. J Med Genet. 55:372–377. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mamrak NE, Shimamura A and Howlett NG:
Recent discoveries in the molecular pathogenesis of the inherited
bone marrow failure syndrome Fanconi anemia. Blood Rev. 31:93–99.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Reid S, Schindler D, Hanenberg H, Barker
K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, et al:
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and
predispose to childhood cancer. Nat Genet. 39:162–164.
2007.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Fang CB, Wu HT, Zhang ML, Liu J and Zhang
GJ: Fanconi anemia pathway: Mechanisms of breast cancer
predisposition development and potential therapeutic targets. Front
Cell Dev Biol. 8(160)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
McReynolds LJ, Biswas K, Giri N, Sharan SK
and Alter BP: Genotype-cancer association in patients with Fanconi
anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN
(PALB2). Cancer Genet. 258-259:101–109. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kottemann MC and Smogorzewska A: Fanconi
anaemia and the repair of Watson and Crick DNA crosslinks. Nature.
493:356–363. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bick G, Zhang F, Meetei AR and Andreassen
PR: Coordination of the recruitment of the FANCD2 and PALB2 Fanconi
anemia proteins by an ubiquitin signaling network. Chromosoma.
126:417–430. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu
J, Christ N, Liu X, Jasin M, Couch FJ and Livingston DM: Control of
BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Mol Cell. 22:719–729. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xia B, Dorsman JC, Ameziane N, de Vries Y,
Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, et al:
Fanconi anemia is associated with a defect in the BRCA2 partner
PALB2. Nat Genet. 39:159–161. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Ghazwani Y, AlBalwi M, Al-Abdulkareem I,
Al-Dress M, Alharbi T, Alsudairy R, Alomari A, Aljamaan K, Essa M,
Al-Zahrani M and Alsultan A: Clinical characteristics and genetic
subtypes of Fanconi anemia in Saudi patients. Cancer Genet.
209:171–176. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Toksoy G, Uludağ Alkaya D, Bagirova G,
Avcı Ş, Aghayev A, Günes N, Altunoğlu U, Alanay Y, Başaran S,
Berkay EG, et al: Clinical and molecular characterization of
Fanconi anemia patients in Turkey. Mol Syndromol. 11:183–196.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Siraj AK, Bu R, Parvathareddy SK, Iqbal K,
Azam S, Qadri Z, Al-Rasheed M, Haqawi W, Diaz M, Victoria IG, et
al: PALB2 germline mutations in a large cohort of Middle Eastern
breast-ovarian cancer patients. Sci Rep. 13(7666)2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cheng HF, Tsai YF, Liu CY, Hsu CY, Lien
PJ, Lin YS, Chao TC, Lai JI, Feng CJ, Chen YJ, et al: Prevalence of
BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese
breast cancer assays with tumor-only targeted sequencing: Extended
data analysis from the VGH-TAYLOR study. Breast Cancer Res.
25(152)2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yadav S, Boddicker NJ, Na J, Polley EC, Hu
C, Hart SN, Gnanaolivu RD, Larson N, Holtegaard S, Huang H, et al:
Contralateral breast cancer risk among carriers of germline
pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. J Clin
Oncol. 41:1703–1713. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Alfares A, Alfadhel M, Wani T, Alsahli S,
Alluhaydan I, Al Mutairi F, Alothaim A, Albalwi M, Al Subaie L,
Alturki S, et al: A multicenter clinical exome study in unselected
cohorts from a consanguineous population of Saudi Arabia
demonstrated a high diagnostic yield. Mol Genet Metab. 121:91–95.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Abdulkareem AA, Abulnaja KO, Jan MM, Karim
S, Rasool M, Ansari SA, Chaudhary AG, Al-Qahtani MH and Naseer MI:
A novel homozygous nonsense mutation in CCDC88A gene cause
PEHO-like syndrome in consanguineous Saudi family. Neurol Sci.
40:299–303. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bruford EA, Braschi B, Denny P, Jones TEM,
Seal RL and Tweedie S: Guidelines for human gene nomenclature. Nat
Genet. 52:754–758. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Naseer MI, Abdulkareem AA, Pushparaj PN,
Bibi F and Chaudhary AG: Exome analysis identified novel homozygous
splice site donor alteration in NT5C2 gene in a Saudi family
associated with spastic diplegia cerebral palsy, developmental
delay, and intellectual disability. Front Genet.
11(14)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Naseer MI, Abdulkareem AA, Muthaffar OY,
Sogaty S, Alkhatabi H, Almaghrabi S and Chaudhary AG: Whole exome
sequencing identifies three novel mutations in the ASPM gene from
Saudi families leading to primary microcephaly. Front Pediatr.
8(627122)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lobitz S and Velleuer E: Guido Fanconi
(1892-1979): A jack of all trades. Nat Rev Cancer. 6:893–898.
2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Adamo A, Collis SJ, Adelman CA, Silva N,
Horejsi Z, Ward JD, Martinez-Perez E, Boulton SJ and La Volpe A:
Preventing nonhomologous end joining suppresses DNA repair defects
of Fanconi anemia. Mol Cell. 39:25–35. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lymphangiectasia. In: Rheumatology and
Immunology Therapy. Abbott JD, Ball G, Boumpas D, Bridges SL,
Chatham W, Curtis J, Daniel C, Hughes LB, Kao AH, Langford C, et
al (eds). Springer Berlin Heidelberg, Berlin, Heidelberg,
pp555-556, 2004.
|
|
30
|
Fiesco-Roa MO, Giri N, McReynolds LJ, Best
AF and Alter BP: Genotype-phenotype associations in Fanconi anemia:
A literature review. Blood Rev. 37(100589)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chang L, Zhang L, An W, Wan Y, Cai Y, Lan
Y, Zhang A, Liu L, Ruan M, Liu X, et al: Phenotypic and genotypic
correlation evaluation of 148 pediatric patients with Fanconi
anemia in a Chinese rare disease cohort. Clin Chim Acta. 539:41–49.
2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Byrd PJ, Stewart GS, Smith A, Eaton C,
Taylor AJ, Guy C, Eringyte I, Fooks P, Last JI, Horsley R, et al: A
hypomorphic PALB2 allele gives rise to an unusual form of FA-N
associated with lymphoid tumour development. PLoS Genet.
12(e1005945)2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ng PS, Pan JW, Ahmad Zabidi MM, Rajadurai
P, Yip CH, Reuda OM, Dunning AM, Antoniou AC, Easton DF, Caldas C,
et al: Characterisation of PALB2 tumours through whole-exome and
whole-transcriptomic analyses. NPJ Breast Cancer.
7(46)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wiltshire T, Ducy M, Foo TK, Hu C, Lee KY,
Belur Nagaraj A, Rodrigue A, Gomes TT, Simard J, Monteiro ANA, et
al: Functional characterization of 84 PALB2 variants of uncertain
significance. Genet Med. 22:622–632. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Siddiqui F, Ansari S, Agha A, Nusrat N,
Munzir S, Shan S, Hanifa A, Farzana T Sr, Taj M, Borhany M, et al:
Chromosomal breakage in Fanconi anemia and consanguineous
marriages: A social dilemma for developing countries. Cureus.
12(e10440)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ben Haj Ali A, Messaoud O, Elouej S,
Talmoudi F, Ayed W, Mellouli F, Ouederni M, Hadiji S, De
Sandre-Giovannoli A, Delague V, et al: FANCA gene mutations in
North African Fanconi anemia patients. Front Genet.
12(610050)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yang Y, Muzny DM, Reid JG, Bainbridge MN,
Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, et al:
Clinical whole-exome sequencing for the diagnosis of mendelian
disorders. N Engl J Med. 369:1502–1511. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lee H, Deignan JL, Dorrani N, Strom SP,
Kantarci S, Quintero-Rivera F, Das K, Toy T, Harry B, Yourshaw M,
et al: Clinical exome sequencing for genetic identification of rare
Mendelian disorders. JAMA. 312:1880–1887. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yang Y, Muzny DM, Xia F, Niu Z, Person R,
Ding Y, Ward P, Braxton A, Wang M, Buhay C, et al: Molecular
findings among patients referred for clinical whole-exome
sequencing. JAMA. 312:1870–1879. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Viakhireva I, Musatova E, Bessonova L,
Shcherbatyuk Y, Korobkov S, Zhikriveckaya S, Sofronova Y, Mironova
I, Khmelkova D, Konovalov F, et al: Novel intronic variant in PALB2
gene and effective prevention of Fanconi anemia in family. Fam
Cancer. 19:241–246. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Serra A, Eirich K, Winkler AK, Mrasek K,
Göhring G, Barbi G, Cario H, Schlegelberger B, Pokora B, Liehr T,
et al: Shared copy number variation in simultaneous nephroblastoma
and neuroblastoma due to Fanconi anemia. Mol Syndromol. 3:120–130.
2012.PubMed/NCBI View Article : Google Scholar
|
